| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Epoxide hydrolase 1 |
|---|
| Ligand | BDBM50295538 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_580017 (CHEMBL1051705) |
|---|
| IC50 | >100000±n/a nM |
|---|
| Citation |  Shen, HC; Ding, FX; Wang, S; Deng, Q; Zhang, X; Chen, Y; Zhou, G; Xu, S; Chen, HS; Tong, X; Tong, V; Mitra, K; Kumar, S; Tsai, C; Stevenson, AS; Pai, LY; Alonso-Galicia, M; Chen, X; Soisson, SM; Roy, S; Zhang, B; Tata, JR; Berger, JP; Colletti, SL Discovery of a highly potent, selective, and bioavailable soluble epoxide hydrolase inhibitor with excellent ex vivo target engagement. J Med Chem52:5009-12 (2010) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Epoxide hydrolase 1 |
|---|
| Name: | Epoxide hydrolase 1 |
|---|
| Synonyms: | EPHX | EPHX1 | EPOX | Epoxide hydrolase (EH) | Epoxide hydrolase (HsEH) | Epoxide hydrolase 1 | HYEP_HUMAN | Microsomal epoxide hydrolase |
|---|
| Type: | Protein |
|---|
| Mol. Mass.: | 52954.28 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | P07099 |
|---|
| Residue: | 455 |
|---|
| Sequence: | MWLEILLTSVLGFAIYWFISRDKEETLPLEDGWWGPGTRSAAREDDSIRPFKVETSDEEI
HDLHQRIDKFRFTPPLEDSCFHYGFNSNYLKKVISYWRNEFDWKKQVEILNRYPHFKTKI
EGLDIHFIHVKPPQLPAGHTPKPLLMVHGWPGSFYEFYKIIPLLTDPKNHGLSDEHVFEV
ICPSIPGYGFSEASSKKGFNSVATARIFYKLMLRLGFQEFYIQGGDWGSLICTNMAQLVP
SHVKGLHLNMALVLSNFSTLTLLLGQRFGRFLGLTERDVELLYPVKEKVFYSLMRESGYM
HIQCTKPDTVGSALNDSPVGLAAYILEKFSTWTNTEFRYLEDGGLERKFSLDDLLTNVML
YWTTGTIISSQRFYKENLGQGWMTQKHERMKVYVPTGFSAFPFELLHTPEKWVRFKYPKL
ISYSYMVRGGHFAAFEEPELLAQDIRKFLSVLERQ
|
|
|
|---|
| BDBM50295538 |
|---|
| n/a |
|---|
| Name | BDBM50295538 |
|---|
| Synonyms: | 4-(3-methyl-1,2,4-oxadiazol-5-yl)-N-(2-phenylcyclopropyl)piperidine-1-carboxamide | CHEMBL564547 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C18H22N4O2 |
|---|
| Mol. Mass. | 326.3929 |
|---|
| SMILES | Cc1noc(n1)C1CCN(CC1)C(=O)NC1CC1c1ccccc1 |
|---|
| Structure | 
|
|---|
Search and Browse
